跳至主要内容
临床试验/NCT03068494
NCT03068494已完成不适用

Multicenter, Retrospective Korean Coronary Bifurcation Stenting (COBIS) Registry III

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 2,648 人开始时间: 2017年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,648
试验地点
1
主要终点
Target lesion failure

研究概览

简要总结

The COBIS III registry is a multi-center, real-world registry of 2nd generation drug-eluting stenting in coronary bifurcation lesions in South Korea. From 21 major coronary intervention centers in Korea, a total of 3,000 patients (anticipated) will be enrolled in this database between January 2010 and December 2014.

The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with 2nd generation drug-eluting stents for coronary bifurcation lesions in South Korea.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >=19 years
  • Any type of de novo bifurcation lesion in major epicardial artery: unprotected left main coronary bifurcation lesion, LAD - diagonal, LCX-OM, distal RCA bifurcation. (Excluding RCA-RV branch bifurcation, branch bifurcation)
  • Side branch or LCX reference diameter >= 2.3 mm and at least stentable with 2.5 mm stent
  • Treated with drug-eluting stent during the period of

排除标准

  • Protected left main disease previous CABG for LAD or LCX territory
  • Cardiogenic Shock
  • History of CPR in the same hospitalization
  • Patients with severe left ventricular systolic dysfunction (ejection fraction < 30%)

结局指标

主要结局

Target lesion failure

时间窗: 5 years

composite of cardiac death, myocardial infarction, or target lesion revascularization

次要结局

  • Cardiac death(5 years)
  • Myocardial infarction(5 years)
  • Target lesion revascularization(3 years)
  • Stent thrombosis(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyeon-Cheol Gwon

Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验